Firms

Sambrinvest
Charleroi, Belgium
Sambrinvest is a public-private regional investor based in Charleroi, Belgium, providing equity capital and financing to startups, growing SMEs and businesses undergoing succession. Its exact legal company is Société de Développement et de Participation du Bassin de Charleroi, abbreviated Sambrinvest, a Belgian société anonyme with enterprise number 0427.908.867. The official Belgian enterprise register confirms its January 9, 1985 establishment and current office at 6 Quai Arthur Rimbaud, Charleroi. Its own historical annual report describes an initial partnership between the Walloon Region and private shareholders. The current strategy covers life sciences, industry, materials, agrifood and structural real-estate projects. Its NEUVASQ investment supports a blood-brain-barrier therapeutic platform, while the June 2025 Elkedonia seed financing supports research on depression and neuropsychiatric disease. These are research-stage company investments, not evidence of clinical approval or treatment efficacy. Its own portfolio directory mixes participated companies and ecosystem partners; a logo listing alone is not treated as a cash equity transaction. Sambrinvest publishes 19 operating staff and 12 governance members. Grégoire Dupuis is CEO, Helena Pozios Head of Venture Capital and Simon Bullman board chair. The official register identifies Cédric Slegers as permanent representative of the corporate director Cometsambre, rather than an additional individual statutory director. Shared Wallonie Entreprendre governance people remain separate affiliations. Its own website reports more than EUR200 million under management and nearly 300 SMEs in portfolio; these figures are not a new fund close or cash financing. European Venture Capital for Charleroi is a EUR28.2 million public co-funded investment programme launched in June 2024 with FEDER and Walloon Region support, distinct from a conventional private LP fund closing. Historical corporate financing vehicles include Fonds de Capitaux d’Amorçage, Fonds de Capital à Risque Objectif n°1 and the leasing/property subsidiary Sambrelease. Incorporation dates, corporate capital, investment decisions and financing plans are not recorded as undisclosed external fund closes.
- Founded
- 1985
- Type
- Venture capital





































